We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Zeiss Light and Electron Microscopy Combined in New Business Group

By LabMedica International staff writers
Posted on 28 Nov 2011
The Carl Zeiss Group (Gottingen, Germany) has launched a new microscopy business group that combines microimaging and nanotechnology systems. More...
In the future, the company will be the world's only supplier to offer one-stop, innovative systems, and solutions for light and electron microscopy.

Customers are increasingly using both systems and want integrated software and workflow solutions. The combination of Carl Zeiss MicroImaging and Nanotechnology Systems into one business group fully reflects this trend.

"By fusing the two worlds of microscopy, we are opening up totally new perspectives to our customers in science and industry," says Dr. Ulrich Simon, head of Carl Zeiss Microscopy. "Carl Zeiss has been a pioneer in this field for more than 160 years. Carl Zeiss and Ernst Abbe together invented scientific microscopy more than 160 years ago. Since then, the company has constantly played a crucial role in shaping the progress of this technology. We are now opening an exciting new chapter in this success story."

The potential offered by combining light and electron microscopy is illustrated by Prof. Jeff Lichtman of Harvard University (Cambridge, MA, USA), who is pioneering brain mapping with light and electron microscopy by generating three-dimensional maps of the brain.

Competition is increasing all over the world: microscopy is a fast-growing market because it is increasingly developing into a basic technology that is now firmly established in many different fields. It is a market that is characterized by big providers and small specialists for specific technologies. The new Carl Zeiss Microscopy business group combines two strengths: it has the right size to carry clout and offers technological expertise covering the entire microscopy process.

Related Links:
Carl Zeiss Group
Harvard University



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Automated Staining Unit
RAL Stainer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.